Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2008-01-12
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The blood samples from mothers and infant pairs were collected approximately one week apart. The blood was spun down, plasma separated and transferred into storage vials immediately. Plasma and blood pellets were stored in cryovials at -70 until analysis.
All women were also requested to provide one breast milk and one urine sample.
Plasma, blood pellet, urine, and breast milk was stored at -70 degrees celcius until analysis.
Plasma was analyzed for iron, transferrin receptor, ferritin, cobalamin, folate, vitamin A, vitamin D, vitamin E, several amino acids and other micronutrient related metabolites.
The breast milk will be analyzed for iodine, fatty acids, and several B vitamins
The urine was analyzed for iodine.
In phase 2, after 5 years we revisited the mother-child pairs and measured growth, diet, food security, and neurodevelopment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no ongoing illness
* resides in the selected cluster
* that household information could be obtained
* that the mother was lactating
Exclusion Criteria
* chronic illness
2 Months
11 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tribhuvan University, Nepal
OTHER
Harvard School of Public Health (HSPH)
OTHER
Oslo and Akershus University of Applied Sciences
UNKNOWN
Centre For International Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tor A Strand, MD/PhD
Role: PRINCIPAL_INVESTIGATOR
University of Bergen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Siddhi Memorial Hospital (SMH),Bhelukhel, Bhimsensthan
Bhaktapur, , Nepal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
172226
Identifier Type: -
Identifier Source: org_study_id